RT Journal
A1 Wright JT, Jr, Probstfield JL, Cushman WC, et al
T1 ALlhat findings revisited in the context of subsequent analyses, other trials, and meta-analyses—reply
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2009
FD October 26
VO 169
IS 19
SP 1806
OP 1818
DO 10.1001/archinternmed.2009.372
UL http://dx.doi.org/10.1001/archinternmed.2009.372
AB 

			We appreciate the favorable comments by Dr Onuigbo on this latest ALLHAT publication.1 We were also impressed by the very positive findings in thiazide-treated patients. ALLHAT was designed to determine whether α-blockers, ACEIs, or CCBs were superior to thiazide-type diuretics (prescribed at an appropriate dosage) as initial therapy for reduction of cardiovascular or renal outcomes.1 While potentially understated, we believe that our overall conclusion that the thiazide-type diuretic was not surpassed is consistent with the data and trial objectives.